Inventiva (IVA) Change in Working Capital (2019 - 2025)
Inventiva (IVA) posted quarterly Change in Working Capital of $9.0 million for Q4 2022, up 15978.73% year-over-year from N/an in Q4 2021, and down 2.22% quarter-over-quarter from $9.2 million in Q3 2022.
Inventiva (IVA) Change in Working Capital (2019 - 2025) Analysis & Trends
Inventiva's Change in Working Capital history runs 4 years deep, the most recent figure standing at $9.0 million for Q4 2022.
- In Q4 2022, Change in Working Capital rose 15978.73% year-over-year to $9.0 million; the TTM figure through Dec 2022 stood at $35.8 million (changed N/A YoY), while the FY2025 annual figure was -$7.8 million, down 3.81% from the prior year.
- Change in Working Capital for Q4 2022 stood at $9.0 million, down from $9.2 million in the prior quarter.
- The five-year high for Change in Working Capital was $17.5 million in Q4 2020, with the low at $19924.0 in Q4 2019.
- The 4-year median for Change in Working Capital is $9.0 million (2022), against an average of $7.2 million.
- The sharpest annual moves came in 2020 and 2021: Change in Working Capital jumped 87831.77% in 2020, then sank 99.68% in 2021.
- Inventiva's Change in Working Capital stood at $19924.0 in 2019, then jumped by 87831.77% to $17.5 million in 2020, then tumbled by 99.68% to $56054.6 in 2021, then surged by 15978.73% to $9.0 million in 2022.
- Business Quant data shows IVA's Change in Working Capital at $9.0 million in Q4 2022, $9.2 million in Q3 2022, and $56054.6 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Dec 31, 2022 | 9.01 Mn |
| Dec 31, 2022 | 9.01 Mn |
| Sep 22, 2022 | 9.22 Mn |
| Sep 22, 2022 | 9.22 Mn |
| Dec 31, 2021 | 56,054.58 |
| Dec 31, 2021 | 56,054.58 |
| Dec 31, 2020 | 17.52 Mn |
| Dec 31, 2020 | 17.52 Mn |
| Dec 31, 2019 | 19,923.98 |
| Dec 31, 2019 | 19,923.98 |